1. Home
  2. NKTX vs RAIL Comparison

NKTX vs RAIL Comparison

Compare NKTX & RAIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NKTX
  • RAIL
  • Stock Information
  • Founded
  • NKTX 2015
  • RAIL 1901
  • Country
  • NKTX United States
  • RAIL United States
  • Employees
  • NKTX N/A
  • RAIL N/A
  • Industry
  • NKTX Biotechnology: Pharmaceutical Preparations
  • RAIL Railroads
  • Sector
  • NKTX Health Care
  • RAIL Industrials
  • Exchange
  • NKTX Nasdaq
  • RAIL Nasdaq
  • Market Cap
  • NKTX 123.5M
  • RAIL 121.5M
  • IPO Year
  • NKTX 2020
  • RAIL N/A
  • Fundamental
  • Price
  • NKTX $1.74
  • RAIL $7.91
  • Analyst Decision
  • NKTX Strong Buy
  • RAIL
  • Analyst Count
  • NKTX 6
  • RAIL 0
  • Target Price
  • NKTX $14.80
  • RAIL N/A
  • AVG Volume (30 Days)
  • NKTX 422.6K
  • RAIL 240.2K
  • Earning Date
  • NKTX 05-14-2025
  • RAIL 05-05-2025
  • Dividend Yield
  • NKTX N/A
  • RAIL N/A
  • EPS Growth
  • NKTX N/A
  • RAIL N/A
  • EPS
  • NKTX N/A
  • RAIL N/A
  • Revenue
  • NKTX N/A
  • RAIL $494,657,000.00
  • Revenue This Year
  • NKTX N/A
  • RAIL $3.03
  • Revenue Next Year
  • NKTX N/A
  • RAIL $7.03
  • P/E Ratio
  • NKTX N/A
  • RAIL N/A
  • Revenue Growth
  • NKTX N/A
  • RAIL 12.90
  • 52 Week Low
  • NKTX $1.31
  • RAIL $3.02
  • 52 Week High
  • NKTX $8.23
  • RAIL $16.10
  • Technical
  • Relative Strength Index (RSI)
  • NKTX 45.11
  • RAIL 63.52
  • Support Level
  • NKTX $1.70
  • RAIL $6.86
  • Resistance Level
  • NKTX $1.82
  • RAIL $7.48
  • Average True Range (ATR)
  • NKTX 0.10
  • RAIL 0.37
  • MACD
  • NKTX -0.01
  • RAIL 0.06
  • Stochastic Oscillator
  • NKTX 18.82
  • RAIL 90.37

About NKTX Nkarta Inc.

Nkarta Inc is a clinical-stage biopharmaceutical company pioneering the development of allogeneic, off-the-shelf engineered natural killer (NK) cell therapies. The Company is engaged in leveraging the natural potent power of NK cells to identify and kill abnormal cells and recruit adaptive immune effectors to generate responses that are specific and durable. The company is combining its NK expansion platform technology with proprietary cell engineering technologies to generate an abundant supply of NK cells, engineer enhanced NK cell recognition of therapeutic targets, and improve persistence for sustained activity in the body for the treatment of cancer.

About RAIL FreightCar America Inc.

FreightCar America Inc is a manufacturer of railcars and components, serving diverse transportation needs primarily in North America. The company designs and produces a wide range of railcar types, including box cars, hoppers, covered hoppers, gondolas, and flat cars for both intermodal and non-intermodal freight. Its clientele includes shippers, railroads, and financial institutions. The company has two segments: Manufacturing and Parts. The Manufacturing segment encompasses new railcar manufacturing, used railcar sales, leasing, and major rebuilds, while the Parts segment, along with corporate activities, constitutes Corporate and Other. The company's revenue is predominantly derived from its Manufacturing segment, with all revenue generated within the United States.

Share on Social Networks: